Premium
Experience of Continuous Subcutaneous Insulin Infusion in the Outpatient Management of Diabetic Teenagers
Author(s) -
Knight G.,
Boulton A. J. M.,
Ward J. D.
Publication year - 1986
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1986.tb00714.x
Subject(s) - medicine , discontinuation , diabetes mellitus , insulin , insulin pump , pediatrics , surgery , intensive care medicine , type 1 diabetes , endocrinology
Of forty‐five adolescent diabetic patients offered continuous subcutaneous insulin infusion (CSII) as part of a large feasibility study, 13 (28.9%) initially chose the treatment, but only 4 out of 11 who actually started CSII continued for one year (64% discontinuation rate). In contrast 30.4% of adults approached chose CSII, and 32% had discontinued after one year. Improvement in glycaemic control was poor, and clinical problems were more common in pump‐treated teenagers than in adults. CSII does not appear to be a therapeutic solution for adolescents having difficult management problems.